Can Rezdiffra lead to weight loss and how can it be combined with weight loss medicines as part of your MASH treatment?
Blog
-
December 18, 2024
-
December 18, 2024
All you should know about the newest treatment for COPD, including how it compares to other medicines.
-
December 04, 2024
What are the latest clinical trial results for zolbetuximab in pancreatic cancer, and is approval expected soon?
-
November 19, 2024
When is Ketas (ibudilast) expected to be approved in the USA, EU, and more? And how can you start your ALS treatment in the meantime?
-
October 15, 2024
-
October 01, 2024
Where is Kisqali (ribociclib) approved as an adjuvant treatment for early breast cancer (and how to get it if it's not yet in your country)?
-
September 24, 2024
How to get the new vitiligo ointment from a trusted supplier in India?
-
September 03, 2024
Odronextamab may not have gotten FDA approval, but it's on its way to getting the EMA's green light. Here's what that means for you as a US patient.
-
August 27, 2024
Why was Blenrep pulled off the market, is it still available, and will it get approval again?
-
July 16, 2024
When will non-US patients have access to Enhertu as a tumor-agnostic treatment.
-
July 02, 2024
How is the new vigabatrin oral solution different from other treatments for infantile spasms? And can it be a Sabril alternative?
-
June 25, 2024
When will the newest treatment for extensive-stage small cell lung cancer be available to patients in Europe (and worldwide)?
-
May 14, 2024
Can lurbinectedin be used to treat Ewing sarcoma and neuroendocrine tumors? The latest data and likely approval timelines.
-
May 14, 2024
Relyvrio is being pulled off the market. What does it mean for you and your treatment?
-
May 08, 2024
Who qualifies for treatment with lecanemab? And how non-US patients can get the medicine if their doctor prescribes it.
-
Fruquintinib clinical trials in gastric cancer are showing promising results. Will the medicine be approved for this indication soon?
-
April 23, 2024
Will Zepzelca be available to European and UK patients soon? Here's what we know, and your options if you can't wait.
-
April 16, 2024
Can givinostat be used to treat polycythemia vera? Here's what clinical trial data show.
-
April 16, 2024
When will the new nonsteroidal treatment for Duchenne be available in the EU and the UK?
-
Could Tivdak treat more than cervical cancer? Here's the latest overview of trials focusing on ovarian, head and neck cancers, and more.
-
April 02, 2024
When will European patients have access to the newest FDA-approved neuroblastoma treatment?
-
April 02, 2024
Iptacopan will soon be approved in Europe, but when will it be available to patients?
-
March 26, 2024
Zynyz(retifanlimab) may have a larger role to play in cancer treatment. Find out the latest research in renal cell carcinoma and more.
-
March 26, 2024
When will Wainua be available to patients in Europe and the UK? The latest news and all your options in the meantime.
-
March 19, 2024
Toripalimab is being studied as a treatment of NSCLC, oesophageal cancer, melanoma, and more. What does research tell us, and what does it mean for you?
-
March 19, 2024
Can Balversa be used to treat breast cancer? What we know from research, and what it means for you.
-
March 12, 2024
Toripalimab may get its EMA and MHRA approvals soon, but when will it be available to patients? All you need to know.
-
March 12, 2024
When will Tivdak be available to patients in Europe and the UK? All you need to know, and all your options to get the treatment quicker.
-
March 05, 2024
Zynyz is close to EMA approval, but it won't be immediately available everywhere in Europe. Here's how to get the treatment at your own timeline.
-
March 05, 2024
Erdafitinib may get its EMA approval in 2024, but when will it be available on the market?